TrialFrontiers in endocrinology2025
Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.
Yazhao Mei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it